Your browser is no longer supported. Please, upgrade your browser.
AMGN Amgen Inc. daily Stock Chart
Amgen Inc.
IndexS&P 500 P/E17.25 EPS (ttm)12.88 Insider Own0.22% Shs Outstand588.65M Perf Week-2.14%
Market Cap130.76B Forward P/E12.98 EPS next Y17.11 Insider Trans-3.55% Shs Float585.09M Perf Month-6.51%
Income7.84B PEG2.33 EPS next Q3.78 Inst Own81.20% Short Float1.61% Perf Quarter0.67%
Sales23.36B P/S5.60 EPS this Y2.00% Inst Trans0.32% Short Ratio4.26 Perf Half Y9.34%
Book/sh16.31 P/B13.62 EPS next Y9.02% ROA12.90% Target Price246.05 Perf Year18.84%
Cash/sh15.14 P/C14.67 EPS next 5Y7.40% ROE74.30% 52W Range166.30 - 244.99 Perf YTD-7.85%
Dividend6.40 P/FCF26.03 EPS past 5Y14.00% ROI21.20% 52W High-9.02% Beta1.13
Dividend %2.88% Quick Ratio1.20 Sales past 5Y3.10% Gross Margin81.40% 52W Low34.03% ATR4.67
Employees23400 Current Ratio1.40 Sales Q/Q-0.50% Oper. Margin41.40% RSI (14)40.61 Volatility1.47% 2.07%
OptionableYes Debt/Eq3.09 EPS Q/Q-5.20% Profit Margin33.60% Rel Volume0.68 Prev Close222.14
ShortableYes LT Debt/Eq2.79 EarningsJan 30 AMC Payout44.80% Avg Volume2.21M Price222.88
Recom2.30 SMA20-1.07% SMA50-4.66% SMA2009.01% Volume1,096,923 Change0.34%
Jan-31-20Downgrade Robert W. Baird Neutral → Underperform $173 → $185
Jan-21-20Upgrade Evercore ISI In-line → Outperform
Dec-24-19Initiated Raymond James Mkt Perform
Dec-17-19Resumed Morgan Stanley Overweight $280
Nov-12-19Initiated SunTrust Buy $256
Nov-05-19Upgrade Cantor Fitzgerald Neutral → Overweight $230 → $255
Oct-17-19Resumed BofA/Merrill Neutral $215
Aug-19-19Downgrade Mizuho Buy → Neutral $208 → $212
May-23-19Upgrade Citigroup Neutral → Buy
May-21-19Initiated Credit Suisse Outperform $208
Jan-28-19Downgrade Evercore ISI Outperform → In-line
Oct-01-18Initiated Cantor Fitzgerald Neutral $223
Apr-05-18Reiterated Barclays Equal Weight $190 → $180
Feb-12-18Reiterated Mizuho Buy $192 → $200
Jan-23-18Upgrade Argus Hold → Buy
Nov-01-17Downgrade Argus Buy → Hold
Oct-26-17Reiterated RBC Capital Mkts Sector Perform $192 → $188
Sep-28-17Reiterated Mizuho Buy $183 → $198
Sep-15-17Initiated RBC Capital Mkts Sector Perform $192
Jul-11-17Resumed Jefferies Buy
Feb-21-20 11:10AM  Pharmaceutical companies develop system to better track counterfeit drugs Reuters
Feb-20-20 11:42AM  Nations largest insurer invests in Waltham healthcare AI startup American City Business Journals
11:34AM  Would you tell your innermost secrets to Alexa? How AI therapists could save you time and money on mental health care MarketWatch
Feb-19-20 10:35AM  Revolution Medicines Joins Amgen and Mirati in Quest for New Type of Cancer Drugs
08:42AM  Amgen Stock: Is It Time To Buy This Biotech After Its Failed Breakout? Investor's Business Daily
05:44AM  Bull of the Day: Guardant Health (GH) Zacks
Feb-18-20 10:49AM  Amgen Inc. -- Moody's assigns Baa1 rating to Amgen's new sr. unsecured notes; stable outlook Moody's
Feb-17-20 05:00AM  Buckingham's Bets in Biotech MoneyShow
Feb-14-20 09:02AM  Vertex Is the Top Big Biotech, According to Citi. 3 More Stocks It Says to Buy.
Feb-13-20 02:42PM  Leaner, More Agile Teva Sees Brighter Days Ahead
Feb-12-20 08:00PM  RPT-FOCUS-Coronavirus outbreak begins to disrupt booming China drug trials Reuters
12:34PM  Coronavirus outbreak begins to disrupt booming China drug trials Reuters
12:27PM  FOCUS-Coronavirus outbreak begins to disrupt booming China drug trials Reuters
10:30AM  Buy AbbVie for its Growth Prospects, Yield and Low Valuation
Feb-11-20 05:27PM  Can Biotech ETFs Gain on Mixed Q4 Earnings Results? Zacks
09:15AM  J&J Files Application for Darzalex Label Expansion With FDA Zacks
06:14AM  If You Had Bought Amgen (NASDAQ:AMGN) Shares Five Years Ago You'd Have Made 47% Simply Wall St.
Feb-10-20 09:44AM  The Zacks Analyst Blog Highlights: Alphabet, Roche, Amgen, General Electric and Sony Zacks
Feb-07-20 02:45PM  Top Stock Research Reports for Alphabet, Roche & Amgen Zacks
10:49AM  Ligand (LGND) Q4 Earnings & Revenues Top Estimates, Stock Up Zacks
10:28AM  Teva (TEVA) to Report Q4 Earnings: What's in the Cards? Zacks
Feb-06-20 03:45PM  Bristol-Myers' (BMY) Q4 Earnings & Revenues Beat Estimates Zacks
11:59AM  Amgen Stock Relative Strength Climbs Ahead Of Key Drug Data Investor's Business Daily
11:11AM  Sanofi (SNY) Q4 Earnings Top, Sales Miss, Dupixent Strong Zacks
08:29AM  Bristol-Myers Just Reported Earnings. Why Its Stock Is Jumping.
07:00AM  Survivors in Canada are Taking Steps to Reduce the Risk of Another Heart Attack. But is it Enough? CNW Group
Feb-05-20 09:04AM  Amgen Stock Rises 6%
Feb-04-20 02:32PM  Eaton Vance Exits Celgene, Trims Amgen Position
11:50AM  Teva's Two Pivotal Studies on Ajovy in Japan Meet Goal Zacks
10:22AM  Analysts Forecast Huge Upsides for Aimmune, Biohaven
09:03AM  Amgen Stock Rises 3%
Feb-01-20 03:01AM  Edited Transcript of AMGN earnings conference call or presentation 30-Jan-20 10:00pm GMT Thomson Reuters StreetEvents
Jan-31-20 04:41PM  How A Rumored Amgen Takeover Sent This Biotech Stock Flying Investor's Business Daily
01:22PM  Reata Pharma Soars on Amgen Takeover Rumor
12:40PM  The Dow Is Down 521 Points Because Coronavirus Isnt Going Away
11:39AM  Amgen Analysts Sidelined After Q4 Report, Say Valuation Reflects Growth Potential Benzinga
10:32AM  KB Home, National Beverage, Amazon, Visa and Amgen highlighted as Zacks Bull and Bear of the Day Zacks
10:07AM  Amgen Stock Falls 3%
09:09AM  The Daily Biotech Pulse: Amgen Hurt By Generic Competition, Nanoviricides Confirms Working On Wuhan Virus, Arcutis IPO Benzinga
08:54AM  Amgen (AMGN) Stock Down Despite Q4 Earnings & Revenue Beat Zacks
08:52AM  Amgen Beat Earnings Expectations. Heres Why Its Stock Is Dropping.
07:28AM  Amazon Stock Is Rising, IBM Is Climbing, but the Stock Market Is Falling
02:12AM  Stocks - U.S. Futures Lower; Virus Fears Weigh as Earnings Continue
Jan-30-20 06:15PM  Amazon Beats Big on Q4 Bottom Line; Plus V, AMGN Zacks
05:29PM  Amgen 2020 outlook falls short of Street estimates; shares slump Reuters
05:29PM  Amgen 2020 outlook falls short of Street estimates, shares down 3% Reuters
05:25PM  Amgen (AMGN) Q4 Earnings and Revenues Surpass Estimates Zacks
05:18PM  Biotech Giant Amgen Tumbles On Lackluster 2020 Earnings Outlook Investor's Business Daily
04:28PM  Amgen 2020 outlook falls short of Street estimates; shares slump Reuters
04:28PM  Amgen 2020 outlook falls short of Street estimates, shares down 3% Reuters
04:17PM  Amgen quarterly profit beats estimates, 2020 outlook falls short Reuters
04:10PM  Amgen stock slips as quarter beats Street view but outlook doesn't MarketWatch
11:12AM  Q4 GDP 2.1%, In-Line with Q3; Plus Q4 Earnings from VZ, KO & More Zacks
11:12AM  Economic Data Deluge Zacks
11:05AM  Amgen Earnings, Revenue Beat in Q4
10:38AM  Lilly (LLY) Q4 Earnings and Sales Top Estimates, Stock Up Zacks
09:26AM  The Daily Biotech Pulse: Sanofi Reports Positive Readout, Tonix Vaccine Candidate Aces Animal Study, Hologix's Weak Guidance Benzinga
07:19AM  Roche (RHHBY) 2019 Sales Solid on Robust Show by New Drugs Zacks
Jan-29-20 08:56AM  Big Drug/Biotech Stock Earnings on Jan 30: BIIB, ALXN & More Zacks
07:00AM  Amgen Reports Earnings Tomorrow. Heres What to Expect.
Jan-27-20 04:00PM  Amgen Announces Webcast Of 2019 Fourth Quarter And Full Year Financial Results PR Newswire
09:26AM  Amgen (AMGN) to Report Q4 Earnings: What's in the Cards? Zacks
Jan-26-20 10:23AM  The Week Ahead In Biotech: Amgen, Eli Lilly, Pfizer In Earnings Mix, IPO Flow Resumes Benzinga
Jan-24-20 11:05AM  What Lies Ahead for Healthcare ETFs in Q4 Earnings? Zacks
09:31AM  Will Pfizer's (PFE) BioPharma Unit Boost Its Q4 Earnings? Zacks
05:34AM  Amgen Stock Falls 3%
Jan-23-20 12:31PM  Amgen (AMGN) Reports Next Week: Wall Street Expects Earnings Growth Zacks
10:39AM  Amgen Stock Is Poised to Gain in 2020, Analyst Says. Heres Why.
Jan-22-20 09:20AM  5 Big Drug/Biotech Stocks Set to Trump Q4 Earnings Estimates Zacks
09:13AM  Should First Trust Capital Strength ETF (FTCS) Be on Your Investing Radar? Zacks
09:00AM  Free "LabXchange" Science Education Accelerator Launched By Amgen Foundation And Harvard's Faculty Of Arts And Sciences PR Newswire
Jan-21-20 06:13PM  Roche's (RHHBY) Lymphoma Drug Polivy Gets Approval in Europe Zacks
Jan-20-20 03:25PM  Top Stock Reports for Alphabet, JPMorgan & Comcast Zacks
Jan-16-20 09:55AM  Should Value Investors Consider Amgen (AMGN) Stock Now? Zacks
05:00AM  Top Picks 2020- Amgen AMGN MoneyShow
Jan-14-20 01:01PM  Amgen Inc. -- Moody's announces completion of a periodic review of ratings of Amgen Inc. Moody's
09:55AM  Biogen Acquires Early-Stage CNS Drug From Pfizer for $75M Zacks
07:55AM  The Daily Biotech Pulse: PhaseBio To Buy Hypertension Asset, Stemline Falls On Q4 Pre-Announcement, FDA Panel To Review Nektar's Opioid Drug Benzinga
Jan-13-20 04:20PM  Amgen Announces Global Diagnostic Collaborations To Expand Molecular Testing For Patients With Non-Small Cell Lung Cancer PR Newswire
10:13AM  Know These 3 Facts to Avoid Paying Half Your Retirement Income to the IRS - January 13, 2020 Zacks
Jan-10-20 10:00AM  Bet on Favorite Sector ETFs & Stocks This Earnings Season Zacks
Jan-09-20 04:00PM  Amgen To Present At The 38th Annual J.P. Morgan Healthcare Conference PR Newswire
08:43AM  Merck's Keytruda Gets FDA Nod for High-Risk Bladder Cancer Zacks
Jan-08-20 07:48AM  Apellis' (APLS) PNH Drug Betters Alexion's Soliris in Study Zacks
Jan-07-20 04:00PM  Amgen To Present At The Goldman Sachs 12th Annual Healthcare CEOs Unscripted Conference PR Newswire
10:26AM  Waltham biotech's drug bests Alexion's blockbuster Soliris in new trial American City Business Journals
10:02AM  Merck's Keytruda Misses One of Two Goals in Lung Cancer Study Zacks
Jan-06-20 12:10PM  Why Amgen (AMGN) is Poised to Beat Earnings Estimates Again Zacks
08:23AM  Amgen Stock Up in a Year on Pipeline & Biosimilar Progress Zacks
Jan-03-20 02:11PM  Cash-strapped biotech signs deal with Chinese drugmaker BeiGene American City Business Journals
Jan-02-20 09:49AM  4 Reasons Why Investors Should Buy Alexion (ALXN) in 2020 Zacks
08:15AM  BeiGene Announces Closing of Amgen Global Strategic Oncology Collaboration and Equity Investment GlobeNewswire
08:15AM  Amgen Commences Strategic Collaboration With BeiGene to Expand Oncology Presence in China PR Newswire
Jan-01-20 12:00PM  Amgen (AMGN) Upgraded to Buy: Here's What You Should Know Zacks
Dec-31-19 12:01PM  Vascepas Future Looks Rosy, But It Could Still Be Fishy for Amarin Stock InvestorPlace
08:22AM  Heres Why Amarin Stock Slumped Despite the FDA Approval InvestorPlace
Dec-27-19 01:36PM  U.S. Cannabis Stocks Will Make Cheap, Smart Buys in 2020 InvestorPlace
10:42AM  Roche and Gilead Losing Patent Protection on Top Sellers
Dec-26-19 01:37PM  Spectrum Pharmaceuticals shares slide 57% after lung cancer trial misses goals MarketWatch
Dec-25-19 08:20PM  How Did Amgen, Inc. (AMGN) Compare Against Top Hedge Fund Stocks in 2019? Insider Monkey
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta, a pegylated protein to treat cancer patients; Prolia to treat postmenopausal women with osteoporosis; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Xgeva for skeletal-related events prevention; Sensipar/Mimpara to treat secondary hyperparathyroidism; and EPOGEN to treat anemia caused by chronic kidney disease. It also markets other products in various markets, including Kyprolis, Nplate, Vectibix, Repatha, NEUPOGEN, Parsabiv, BLINCYTO, Aimovig, IMLYGIC, Corlanor, MVASI, KANJINTI, EVENITY, AMGEVITA, and Otezla. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with Novartis; UCB; Bayer HealthCare LLC; DaVita Inc.; BeiGene, Ltd.; and QIAGEN N.V. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Williams R SandersDirectorFeb 06Sale233.7242599,3314,988Feb 10 09:33 PM
Piacquad DavidSVP, Business DevelopmentFeb 06Sale229.939,2642,130,07939,700Feb 07 08:25 PM
Meline David WEVP & CFONov 25Sale234.368,7372,047,60349,378Nov 25 06:27 PM
Graham Jonathan PEVP, Gen. Counsel & Secy.Nov 22Sale230.549,0002,074,83742,853Nov 25 06:25 PM
Piacquad DavidSVP, Business DevelopmentNov 20Option Exercise156.355,749898,85653,361Nov 20 08:09 PM
SUGAR RONALD DDirectorNov 06Option Exercise54.712,000109,42016,436Nov 07 06:20 PM
Williams R SandersDirectorNov 06Sale215.4542591,5665,413Nov 07 06:22 PM
SUGAR RONALD DDirectorNov 06Sale215.452,000430,90014,436Nov 07 06:20 PM
SUGAR RONALD DDirectorOct 02Option Exercise54.712,000109,42016,436Oct 03 05:06 PM
SUGAR RONALD DDirectorOct 02Sale193.582,000387,16014,436Oct 03 05:06 PM
SUGAR RONALD DDirectorSep 04Option Exercise54.712,000109,42016,336Sep 04 06:08 PM
SUGAR RONALD DDirectorSep 04Sale206.702,000413,40014,336Sep 04 06:08 PM
Patton Cynthia MSVP & CCOAug 30Option Exercise158.438,6241,366,33132,648Sep 04 06:07 PM
Patton Cynthia MSVP & CCOAug 30Sale208.0713,4262,793,51022,097Sep 04 06:07 PM
SUGAR RONALD DDirectorAug 07Option Exercise54.712,000109,42016,336Aug 08 07:09 PM
Williams R SandersDirectorAug 07Sale183.0442577,7925,838Aug 08 07:12 PM
SUGAR RONALD DDirectorAug 07Sale183.042,000366,08014,336Aug 08 07:09 PM
SUGAR RONALD DDirectorJul 03Option Exercise54.712,000109,42016,336Jul 08 04:23 PM
SUGAR RONALD DDirectorJul 03Sale187.582,000375,16014,336Jul 08 04:23 PM
SUGAR RONALD DDirectorJun 05Option Exercise54.712,000109,42016,219Jun 05 06:55 PM
SUGAR RONALD DDirectorJun 05Sale175.682,000351,36014,219Jun 05 06:55 PM
SUGAR RONALD DDirectorMay 01Option Exercise54.712,000109,42015,092May 03 05:37 PM
SUGAR RONALD DDirectorMay 01Sale175.732,000351,46013,092May 03 05:37 PM
SUGAR RONALD DDirectorApr 03Option Exercise54.712,000109,42015,092Apr 03 06:27 PM
SUGAR RONALD DDirectorApr 03Sale193.182,000386,36013,092Apr 03 06:27 PM
SUGAR RONALD DDirectorMar 06Option Exercise54.712,000109,42014,988Mar 08 07:47 PM
SUGAR RONALD DDirectorMar 06Sale188.882,000377,76012,988Mar 08 07:47 PM